Ernest Han

6.0k total citations
95 papers, 1.5k citations indexed

About

Ernest Han is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ernest Han has authored 95 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Reproductive Medicine, 38 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Ernest Han's work include Ovarian cancer diagnosis and treatment (40 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Intraperitoneal and Appendiceal Malignancies (17 papers). Ernest Han is often cited by papers focused on Ovarian cancer diagnosis and treatment (40 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Intraperitoneal and Appendiceal Malignancies (17 papers). Ernest Han collaborates with scholars based in United States, Netherlands and Australia. Ernest Han's co-authors include Thanh H. Dellinger, Mark T. Wakabayashi, Bradley J. Monk, Wei Wen, John H. Yim, Robert J. Morgan, Robert A. Burger, Mihaela Cristea, Guillermo A. Altenberg and Jun Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ernest Han

86 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernest Han United States 24 557 468 435 305 210 95 1.5k
Thanh H. Dellinger United States 22 542 1.0× 424 0.9× 237 0.5× 203 0.7× 112 0.5× 77 1.3k
Lingya Pan China 22 494 0.9× 228 0.5× 590 1.4× 193 0.6× 134 0.6× 108 1.4k
Gisele Sarosy United States 21 654 1.2× 810 1.7× 358 0.8× 185 0.6× 225 1.1× 38 1.7k
M.E.L. van der Burg Netherlands 27 452 0.8× 961 2.1× 910 2.1× 664 2.2× 417 2.0× 69 2.4k
Stephen Welch Canada 24 626 1.1× 1.0k 2.2× 368 0.8× 176 0.6× 388 1.8× 124 1.9k
Tomoyuki Nagai Japan 24 599 1.1× 528 1.1× 73 0.2× 325 1.1× 409 1.9× 95 1.7k
Agustin A. García United States 31 1.1k 1.9× 1.5k 3.3× 836 1.9× 339 1.1× 681 3.2× 114 3.1k
Beihua Kong China 32 1.2k 2.2× 611 1.3× 1.2k 2.7× 311 1.0× 290 1.4× 121 3.1k
Qianming Bai China 20 412 0.7× 314 0.7× 72 0.2× 287 0.9× 171 0.8× 82 1.2k
G. Veerman Netherlands 20 635 1.1× 1.1k 2.3× 127 0.3× 347 1.1× 730 3.5× 52 1.9k

Countries citing papers authored by Ernest Han

Since Specialization
Citations

This map shows the geographic impact of Ernest Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Han more than expected).

Fields of papers citing papers by Ernest Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Han. The network helps show where Ernest Han may publish in the future.

Co-authorship network of co-authors of Ernest Han

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Han. A scholar is included among the top collaborators of Ernest Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Han. Ernest Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Wei, et al.. (2025). Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin. International Journal of Molecular Sciences. 26(22). 11061–11061.
2.
Han, Ernest, et al.. (2025). From Fallopian Tube to Ovarian Cancer: Understanding the Evaluation and Management of Serous Tubal Intraepithelial Carcinoma Lesions. Current Treatment Options in Oncology. 26(10). 910–919.
3.
Tanyi, János L., Leslie M. Randall, Setsuko K. Chambers, et al.. (2023). A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006). Obstetrical & Gynecological Survey. 78(6). 341–342.
4.
Adamson, A. W., Yuan Chun Ding, Linda Steele, et al.. (2023). Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of Ovarian Research. 16(1). 141–141. 6 indexed citations
5.
Shim, Seung‐Hyuk, Kyeong A So, Sun Joo Lee, et al.. (2021). Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer. Gynecologic Oncology. 161(3). 810–816. 12 indexed citations
6.
Thornblade, Lucas W., Ernest Han, & Yuman Fong. (2021). Colorectal cancer ovarian metastases. International Journal of Gynecological Cancer. 31(8). 1137–1144. 4 indexed citations
7.
Haber, Tom, Soraya Aramburo, Pengpeng Cao, et al.. (2020). Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles. Proceedings of the National Academy of Sciences. 117(33). 19737–19745. 36 indexed citations
8.
Chung, Christopher, Mark T. Wakabayashi, Thanh H. Dellinger, et al.. (2020). Prolapse repair after anterior exenteration. International Urogynecology Journal. 32(4). 1037–1038.
9.
Cristea, Mihaela, Wenge Wang, Mark T. Wakabayashi, et al.. (2019). Highlights of the NCCN Oncology Research Program. Journal of the National Comprehensive Cancer Network. 17(1). xxxvii–xxxvii. 1 indexed citations
10.
Cristea, Mihaela, Wenge Wang, Mark T. Wakabayashi, et al.. (2019). Oncology Research Program. Journal of the National Comprehensive Cancer Network. 17(9). xxvi–xxvi. 1 indexed citations
11.
Li, Jie, Rachael Mooney, Soraya Aramburo, et al.. (2019). Silica Coated Paclitaxel Nanocrystals Enable Neural Stem Cell Loading For Treatment of Ovarian Cancer. Bioconjugate Chemistry. 30(5). 1415–1424. 8 indexed citations
12.
Cristea, Mihaela, Paul Frankel, Timothy W. Synold, et al.. (2019). A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Cancer Chemotherapy and Pharmacology. 83(3). 589–598. 25 indexed citations
13.
Dellinger, Thanh H., et al.. (2018). HIPEC treatment in advanced and recurrent ovarian cancer: a meta-analysis of observational studies. European Journal of Gynaecological Oncology. 39(3). 353–360.
14.
Cao, Pengpeng, Rachael Mooney, Revathiswari Tirughana, et al.. (2017). Intraperitoneal Administration of Neural Stem Cell–Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors. Bioconjugate Chemistry. 28(6). 1767–1776. 38 indexed citations
15.
Eng, Oliver S., Sinziana Dumitra, Michael P. O’Leary, et al.. (2017). Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 24(9). 2707–2711. 6 indexed citations
16.
Dellinger, Thanh H., Amy Hakim, Stephen J. Lee, et al.. (2016). Surgical Management of Vulvar Cancer. Journal of the National Comprehensive Cancer Network. 15(1). 121–128. 39 indexed citations
17.
Han, Ernest, et al.. (2012). Clinical utility of targeted treatments in the management of epithelial ovarian cancer. Biologics. 6. 233–233. 5 indexed citations
18.
Sinsakul, Marvin, Mohammed Sika, Roger A. Rodby, et al.. (2007). A Randomized Trial of a 6-Week Course of Celecoxib on Proteinuria in Diabetic Kidney Disease. American Journal of Kidney Diseases. 50(6). 946–951. 8 indexed citations
19.
Luh, Join Y., et al.. (2002). Poorly Differentiated Colon Carcinoma With Neuroendocrine Features Presenting With Hypercalcemia and Cutaneous Metastases. American Journal of Clinical Oncology. 25(2). 160–163. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thanh H. Dellinger Breakdown of academic impact, for papers by Lingya Pan Breakdown of academic impact, for papers by Gisele Sarosy Breakdown of academic impact, for papers by M.E.L. van der Burg Breakdown of academic impact, for papers by Stephen Welch Breakdown of academic impact, for papers by Tomoyuki Nagai Breakdown of academic impact, for papers by Agustin A. García Breakdown of academic impact, for papers by Beihua Kong Breakdown of academic impact, for papers by Qianming Bai Breakdown of academic impact, for papers by G. Veerman
Rankless by CCL
2026